Merck, Bayer Target Watson Over Generic Beyaz Birth Control
Merck & Cie and Bayer Pharma AG sued Watson Pharmaceuticals Inc. in Delaware federal court on Friday, alleging the company's application to market a generic oral contraceptive infringes a Merck patent...To view the full article, register now.
Already a subscriber? Click here to view full article